Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maroun

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer. a review of phase II/III trialsD Cunningham, J Zalcberg, J Maroun, et al.
American Journal of Clinical Oncology|January 22, 2002
Thymidylate synthase expression in stage II and III colon cancer: a retrospective reviewA Tomiak, M Vincent, C C Earle, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 1, 1991
Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indicationJ R Skillings, M Levine, H L Rayner, et al.
Clinical Colorectal Cancer|November 28, 2002
The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a Multicenter Canadian TrialM Michael, D Hedley, A Oza, et al.
Current Oncology (Toronto, Ont.)|June 23, 2010
Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert GroupW Kocha, J Maroun, H Kennecke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III studyP M Hoff, R Ansari, G Batist, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials GroupG Goss, L L Siu, I Gauthier, et al.
Current Oncology (Toronto, Ont.)|June 20, 2007
Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert GroupJ Maroun, W Kocha, L Kvols, et al.
Current Oncology (Toronto, Ont.)|October 8, 2011
Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinomaM Sherman, K Burak, J Maroun, et al.
Current Oncology (Toronto, Ont.)|August 25, 2015
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014E Tsvetkova, S Sud, N Aucoin, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer. a review of phase II/III trialsD Cunningham, J Zalcberg, J Maroun, et al.
American Journal of Clinical Oncology|January 22, 2002
Thymidylate synthase expression in stage II and III colon cancer: a retrospective reviewA Tomiak, M Vincent, C C Earle, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 1, 1991
Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indicationJ R Skillings, M Levine, H L Rayner, et al.
Clinical Colorectal Cancer|November 28, 2002
The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a Multicenter Canadian TrialM Michael, D Hedley, A Oza, et al.
Current Oncology (Toronto, Ont.)|June 23, 2010
Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert GroupW Kocha, J Maroun, H Kennecke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III studyP M Hoff, R Ansari, G Batist, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials GroupG Goss, L L Siu, I Gauthier, et al.
Current Oncology (Toronto, Ont.)|June 20, 2007
Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert GroupJ Maroun, W Kocha, L Kvols, et al.
Current Oncology (Toronto, Ont.)|October 8, 2011
Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinomaM Sherman, K Burak, J Maroun, et al.
Current Oncology (Toronto, Ont.)|August 25, 2015
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014E Tsvetkova, S Sud, N Aucoin, et al.
Pageof 5